Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Ocular Therapeut (OCUL)

Ocular Therapeut (OCUL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Feb 6, 3:01PM CST

BEDFORD, Mass., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 9.16 (+2.81%)
OCUL
Ocular Therapeutix (NASDAQ:OCUL) Misses Q4 CY2025 Revenue Estimates StockStory - Thu Feb 5, 3:06PM CST

Ocular Therapeutix (NASDAQ:OCUL) Misses Q4 CY2025 Revenue Estimates

OCUL : 9.16 (+2.81%)
Ocular Therapeutix: Q4 Earnings Snapshot AP - Thu Feb 5, 6:12AM CST

Ocular Therapeutix: Q4 Earnings Snapshot

OCUL : 9.16 (+2.81%)
Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights GlobeNewswire - Thu Feb 5, 6:00AM CST

SOL-1 Phase 3 superiority trial results remain masked to date SOL-1 data expected to be presented at the 49 th Macula Society Annual Meeting Ocular plans to submit NDA for AXPAXLI™...

OCUL : 9.16 (+2.81%)
OCUL
A Look Back at Pharmaceuticals Stocks’ Q3 Earnings: Ocular Therapeutix (NASDAQ:OCUL) Vs The Rest Of The Pack StockStory - Mon Jan 26, 9:34PM CST

A Look Back at Pharmaceuticals Stocks’ Q3 Earnings: Ocular Therapeutix (NASDAQ:OCUL) Vs The Rest Of The Pack

OCUL : 9.16 (+2.81%)
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Jan 23, 3:01PM CST

BEDFORD, Mass., Jan. 23, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced...

OCUL : 9.16 (+2.81%)
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer GlobeNewswire - Wed Jan 21, 6:00AM CST

Accomplished global commercial leader with deep expertise in retina drug launches Primary architect for the industry-defining launch of EYLEA ® while at Regeneron Most recently served as...

OCUL : 9.16 (+2.81%)
NMRK
3 Cash-Burning Stocks We’re Skeptical Of StockStory - Mon Jan 19, 10:35PM CST

3 Cash-Burning Stocks We’re Skeptical Of

RKLB : 72.32 (+9.05%)
NMRK : 16.85 (+4.14%)
OCUL : 9.16 (+2.81%)
ABT
1 Healthcare Stock to Consider Right Now and 2 We Find Risky StockStory - Thu Jan 15, 10:36PM CST

1 Healthcare Stock to Consider Right Now and 2 We Find Risky

TXG : 18.61 (+5.14%)
ABT : 110.83 (+1.60%)
OCUL : 9.16 (+2.81%)
OCUL
3 Reasons OCUL is Risky and 1 Stock to Buy Instead StockStory - Tue Jan 13, 10:04PM CST

3 Reasons OCUL is Risky and 1 Stock to Buy Instead

OCUL : 9.16 (+2.81%)

Barchart Exclusives

Should You Buy Uber Stock Now for a ‘Multitrillion-Dollar’ Opportunity in Robotaxis? Barchart - Sat Feb 7, 10:32AM CST
With management betting big on robotaxis as a future growth engine, should you buy Uber stock now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot